Cargando…

When an embarrassment of riches isn’t enough

Data on a new treatment approach utilizing bispecific monoclonal antibodies targetting B-cell maturation antigen (BCMA) were recently published, yielding very encouraging results in the setting of relapsed and/or refractory multiple myeloma (RRMM). How to safely and effectively deliver this treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Krina, Lonial, Sagar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358664/
https://www.ncbi.nlm.nih.gov/pubmed/35941288
http://dx.doi.org/10.1038/s41571-022-00670-w